Jeffrey W. Sherman

Jeffrey W. Sherman

DirectoratLarimar Therapeutics· In proxies 2023–2025

Jeffrey W. Sherman sits on 9 public boards.

Boards1

  • Xeris Biopharma HoldingsDirector · 3 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Larimar TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role -44%
  2. Xeris Biopharma HoldingsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Larimar TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  4. Sorriso Pharmaceuticals, Inc.Public company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  5. StrongbridgePublic company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  6. Annual MeetingPublic company
    • Director? – PresentNo stock prices for these years
  7. Biotechnology Innovation OrganizationPublic company
    • Director? – PresentNo stock prices for these years
  8. Study on Clinical Research ParticipationPublic company
    • Director? – PresentNo stock prices for these years
  9. Xeris Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?